News

BMJ17h
Detection of small joint synovitis by ultrasonography: the learning curve of rheumatologists
Background: Ultrasonography allows assessment of soft tissue structures and has become a valued tool for diagnosing synovitis. Objective: To assess the learning curve for ultrasonography in evaluating ...
BMJ1d
Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis
1 UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland 2 UCD School of Mathematical Sciences, University College Dublin, Dublin, Ireland Objective ...
BMJ1d
Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus
2 Department of Internal Medicine, General Hospital of Kufstein, Kufstein, Austria 3 Department of Internal Medicine I, Innsbruck Medical University, Innsbruck, Austria 4 Department of Internal ...
BMJ2d
Ankylosing spondylitis: an overview
1 Department of Gastroenterology and Rheumatology, Free University, Berlin, Germany 2 Rheumazentrum Ruhrgebiet, Herne, Germany and Department of Gastroenterology and Rheumatology, Free University, ...
BMJ2d
The International Classification of Functioning, Disability and Health (ICF) Core Sets for rheumatoid arthritis: a way to specify functioning
1 Department of Physical Medicine and Rehabilitation, Ludwig-Maximilians-University, Munich, Germany 2 ICF Research Branch of the WHO FIC CC (DIMDI), IMBK—Department of Physical Medicine and ...
BMJ3d
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis
Objectives To assess the efficacy and safety of abatacept, a selective T-cell costimulation modulator, in a phase III study in psoriatic arthritis (PsA). Methods This study randomised patients (1:1) ...
BMJ3d
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial
Objectives Risankizumab is an interleukin-23 inhibitor under study for the treatment of patients with psoriatic arthritis (PsA). The phase 3 KEEPsAKE 2 trial investigated the efficacy and safety of ...
BMJ4d
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis
Objectives Short-term predictive endpoints of chronic kidney disease (CKD) are needed in lupus nephritis (LN). We tested response to therapy at 1 year. Results We studied 381 patients (90.5% ...
BMJ5d
Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study
11 Paris-Descartes University, Medicine Faculty, UPRES-EA 4058 & APHP, Cochin Hospital, Rheumatology B Department, Paris, France Correspondence to Professor Maxime Dougados, Paris-Descartes University ...
BMJ6d
Predictive factors of work disability in rheumatoid arthritis: a systematic literature review
1 Coronel Institute for Occupational and Environmental Health, Academic Medical Centre, Research Institute Amsterdam Centre for Health and Health Care Research (AmCOGG), Amsterdam, The Netherlands 2 ...
BMJ6d
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
19 Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, and 2nd Department of Medicine, Hietzing Hospital, Vienna, Austria 20 Department of Rheumatology, Seoul National ...
BMJ6d
Interpreting radiographic data in rheumatoid arthritis
Plain film radiography is the preferred method for evaluating disease progression in rheumatoid arthritis and for establishing the efficacy of new disease modifying antirheumatic agents. However, the ...